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Biotechnology, Padriciano 99, 34149 Trieste, ItalyAbstract—Amyotrophic lateral sclerosis (ALS) is a fatal neu-
rodegenerative disease. The average age of onset of both
sporadic and familial cases is 50–60 years of age. The pres-
ence of cytoplasmic inclusions of the RNA-binding protein
TARDNA-bindingprotein-43 (TDP-43) in the aﬀectedneurons
is seen in 95% of the ALS cases, which results in TDP-43
nuclear clearance and loss of function. TheDrosophila mela-
nogaster ortholog of TDP-43 (TBPH) shares many character-
istics with the human protein. Using a TDP-43 aggregation
inducer previously developed in human cells, we created a
transgenic ﬂy that shows an adult locomotive defect. Pheno-
type onset correlates with a physiologically age-related drop
of TDP-43/TBPH mRNA and protein levels, seen both in mice
and ﬂies. Artiﬁcial reduction of mRNA levels, in vivo, antici-
pates the locomotion defect to the larval stage. Our study
links, for the ﬁrst time, aggregation and the age-related, evo-
lutionary conserved reduction of TDP-43/TBPH levels with
the onset of an ALS-like locomotion defect in a Drosophila
model. A similar process might trigger the human disease.
 2015 The Authors. Published by Elsevier Ltd. on behalf of
IBRO. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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INTRODUCTION
The major histopathological feature, seen in around 95%
of amyotrophic lateral sclerosis (ALS) patients, is the
presence of cytoplasmic TAR DNA-binding protein-43
(TDP-43) inclusions in the aﬀected neurons (Ling et al.,
2013; Gomez-Deza et al., 2015), resulting in TDP-43
nuclear clearance and loss of TDP-43 nuclear function,
which in turn may lead to cellular dysfunctions
(Neumann et al., 2006; Arai et al., 2006).http://dx.doi.org/10.1016/j.neuroscience.2015.10.037
0306-4522/ 2015 The Authors. Published by Elsevier Ltd. on behalf of IBRO.
This is an open access article under the CC BY-NC-ND license (http://creativecomm
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Abbreviations: 12xQ/N, repeated TDP-43 amino acid sequence
331–369; ALS, amyotrophic lateral sclerosis; CNS, central nervous
system; TDP-43, TAR DNA-binding protein-43; TBPH, TAR
DNA-binding protein-43 Drosophila melanogaster ortholog.
415TDP-43 is a protein that has a marked tendency to
unfold and become insoluble both in vitro and in vivo. In
particular, its C-terminal end has a so-called ‘‘prion-like
domain” between amino acids 331–369 (Udan and
Baloh 2011; Nonaka et al., 2013). This sequence is rich
in Glutamine (Q) and Asparagine (N), and is involved both
in the interactions with other proteins and the self-
aggregation process (D’Ambrogio et al., 2009; Igaz
et al., 2009; Budini et al., 2012; Budini et al., 2014). We
have previously developed a cellular model of aggrega-
tion using the TDP-43 Q/N rich amino acid sequence
repeated 12 times linked to the EGFP sequence. These
cellular inclusions were shown to be capable of seques-
tering the endogenous TDP-43 both in non-neuronal
and neuronal cells (Budini et al., 2012).
The link between aggregate formation and loss of
function, to date is still not fully understood. It has been
suggested that the late onset of ALS in humans may be
due to mitochondrial dysfunction, ineﬀective unfolded
protein response and defects in the autophagy or
proteasome systems (Ling et al., 2013; Cozzolino and
Carrı`, 2012). Indeed, if the clearance system is defective
there will be persistence of aggregates in the cell.
However, this does not provide an explanation for why
the aggregates may persist for many years with no
ALS-related symptoms. In fact, 29% of normal individuals
over 65 years old present TDP-43 inclusions in the brain
(Geser et al., 2010). Furthermore, there is still no answer
to the question of why mutations in TDP-43 or other
TDP-43-ALS related genes do not anticipate the onset
of the symptoms in human patients.
In this work, we have used the EGFP-12xQ/N
aggregation model to explore the connection between
the aggregate formation and the onset of the disease.
We present here data indicating that the combination of
physiological age-related reduction of TAR DNA-binding
protein-43 Drosophila melanogaster ortholog (TBPH)/
TDP-43 levels with the presence of aggregates, that
sequester this protein in the cytoplasm, leads to a
locomotion defect due to the depletion of functional
TDP-43 in a Drosophila ALS model.
EXPERIMENTAL PROCEDURES
Fly stocks
EGFP-12xQ/N (12 repetitions of the TDP-43 amino acids
stretch 331–369 sequence tagged with EGFP) and EGFP
constructs were cloned in the pUASTattB vector. All theons.org/licenses/by-nc-nd/4.0/).
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to create transgenic ﬂies by standard embryo injections
(Best Gene Inc.). Speciﬁc insertion of the transgene
was performed using strain 24486. Transgenic ﬂies
have been subsequently balanced on the required
chromosome.
RNA interference ﬂies for TBPH (ID 38377) were
obtained from VDRC Vienna. W1118 and ELAV-Gal4
were obtained from Bloomington Drosophila Stock
Center at Indiana University. Flies were fed on standard
cornmeal (2.9%), sugar (4.2%), yeast (6.3%) ﬂy food,
maintained and crossed in a humidiﬁed incubator at
25 C (unless stated otherwise) with a 12 h–12 h light–
dark cycle.
Climbing assay
Flies were transferred without anesthesia to a 50 ml
glass-cylinder, taped to the bottom of the tube, and their
subsequent climbing activity was quantiﬁed as the
number of ﬂies that reach the top of the tube in 15 s. At
least 100 ﬂies of each genotype were tested. In each
set of experiments 20 ﬂies (1:1 male:female ratio) were
introduced in the cylinder and tested in triplicate. The
number of top climbing ﬂies was converted into % value,
and the mean % value (±SEM) was calculated for at
least ﬁve experiments.
Life span
Adult ﬂies were collected for 2 days and transferred to
tubes with food. Each tube contained 20 ﬂies in a
proportion 1:1 male:female ratio. Every third day, ﬂies
were transferred to a fresh tube and deaths were
scored. Survival rate was plotted as percentage of
survival ﬂies against day. Approximately 100 ﬂies were
tested of each genotype.
Larval movement
Wandering third instar larvae were selected, washed and
transferred to a Petri dish with a layer of 0.7% agarose.
After a period of adaptation, the peristaltic waves were
counted within 2 min. At least 20 larvae from each
genotype were counted, and the mean was calculated.
Drosophila immunoblotting
Drosophila heads were homogenized in lysis buﬀer
(10 mM Tris–HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA,
5 mM EGTA, 10% Glycerol, 50 mM NaF, 5 mM DTT,
4 M Urea, and protease inhibitors (Roche Diagnostic #
11836170001, Mannheim, Germany)).
Larval brains were dissected in Phosphate Buﬀer with
0.1% Tween 20 (PBT) and collected in Loading Buﬀer
(30 mM Tris, pH 6.8, 9% Glycerol, 2.4% SDS, 3%
2-mercaptoethanol, 0.03% bromophenol blue) and
homogenized.
Proteins were separated by 8% SDS–PAGE,
transferred to nitrocellulose membranes (Whatman #
NBA083C, Clifton, USA) and probed with primary
antibodies: rabbit anti-TBPH (1:1500, home-made),
mouse anti-synapsin (1:4000, Hybridoma Bank # 3C11,Iowa, USA) and mouse anti-tubulin (1:4000, Calbiochem
# CP06, Billerica, USA). The membranes were
incubated with the secondary antibodies: HRP-labeled
anti-mouse (1:1000, Thermo Scientiﬁc # 32430,
Rockford, USA) or HRP-labeled anti-rabbit (1:1000,
Thermo Scientiﬁc # 32460). Finally, protein detection
was assessed with Femto Super Signal substrate
(Thermo Scientiﬁc # 34095).
Protein bands were quantiﬁed using NIH ImageJ. The
intensity of the band of interest was normalized with
tubulin. The respective histogram for each western blot
shows the relative expression of at least two
independent experiments.Mouse immunoblotting
Whole brains were homogenized with mechanical agitator
(ForLab, Bergamo, Italy) in RIPA buﬀer (150 mM NaCl,
1% NP-40, 0.5% DOC, 0.1% SDS, 50 mM Tris HCl,
pH8, 2 protease inhibitors (Roche Diagnostic #
11836170001)). Total protein extracts were separated
by 10% SDS–PAGE, transferred to nitrocellulose
membranes (Whatman # NBA083C) and probed with
primary antibodies: rabbit anti-TDP43 (1:1000,
Proteintech # 10782-2-AP), rabbit anti-synapsin I
(1:1000, abcam # ab18814), rabbit anti GAPDH
(1:1000, Santa Cruz # sc-25778). The membranes were
incubated with the secondary antibodies: HRP-labeled
anti-rabbit (1:1000, Thermo Scientiﬁc # 32460). Finally,
protein detection was assessed with ECL Western
Blotting Substrate (Thermo Scientiﬁc # 32106). Protein
bands were quantiﬁed using NIH ImageJ. The intensity
of the band of interest was normalized with GAPDH.
The histogram for the western blot shows the relative
expression of at least three independent experiments.RNA extraction and real-time PCR
Total RNA was extracted from Drosophila heads (25 C)
with TRIzol reagent (Invitrogen # 15596-026) according
to manufacturer’s instructions. Regarding mouse brain
total RNA, the same protocol was performed with the
exception that the whole brain was homogenized using
a mechanical agitator (ForLab, Bergamo, Italy) in TRIzol
prior to RNA extraction. cDNA was synthesized starting
from 1 lg of total RNA by using Superscript III
(Invitrogen # 18080-044) reverse transcriptase and
OligodT primers. Speciﬁc primers were designed to
amplify TBPH (forward: 50-CGGCAAGCCGAGCACGAT
GAG-30, reverse: 50-CGCGGAGTTCGCTCCAACGAG-30)
and mouse TDP-43 (forward: 50-GCAGTCCA
GAAAACA-30, reverse: 50-CACCATCGCCCATCTA-30).
The expression levels were assessed by real-time PCR
using Rpl-11 as ﬂy housekeeping gene (forward: 50-CCA
TCGGTATCTATGGTCTGGA-30, reverse: 50-CATCG
TATTTCTGCTGGAACCA-30) and GAPDH as mouse
housekeeping gene (forward: 50-AGGTCGGTGT
GAACGG-30, reverse: 50-AGTCATACTGGAACAT-30).
All ampliﬁcations were done on CFX96 real-time PCR
detection system (Biorad) using SYBR Green
technology (Biorad # 720000601). The relative
expression levels were calculated according to the Livak
Fig. 1. EGFP-12xQ/N expression generates no early neurological
toxicity. Quantiﬁcation of peristaltic waves of third instar larvae,
expressing EGFP-12xQ/N or EGFP alone under ELAV-Gal4 driver.
More than 20 larvae from each genotype were counted, and the mean
was calculated. ns indicates p> 0.05 (not signiﬁcant) calculated by
unpaired t-test. Error bars indicate SEM.
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DCT = CT(target)  CT(normalizer) for Ct normalization; and
the diﬀerence between DCT(test) and DCT(calibrator) to
calculate the expression ratio and compare the
expression levels. Statistical signiﬁcance was calculated
using student’s t-test (indicated as * for P 6 0.05 and ns
for not statistically signiﬁcant).
Mouse brain RNA Northern Blotting
Total RNA from mouse brains was isolated as already
described in the real-time PCR section. RNA samples
(20 lg) were loaded on 1% formaldehyde agarose gels,
transferred to Hybond N+ nylon membranes
(Amersham Biosciences # RPN119B) and probed with
internally 32P-labeled sequences following pre-
hybridization in ULTRAhyb Ultrasensitive Hybridization
Buﬀer (Ambion # AM8670). Pre-hybridization and
hybridization were carried out at 40 C. The probes
were generated by PCR using primers Mus TDP-43 ex2
Fw 50-atgggacggtgttgctgt-30 and Mus TDP-43 ex3 Rv
50-agtctttcagatcctgct-30 and labeled with Rediprime II
DNA Labeling System (GE Healthcare # RPN1633).
The probe to detect GAPDH was generated using the
same primers as for the mouse brain real-time PCR.
Visualization of transcripts was carried out with a
Cyclone Plus Storage Phosphor Scanner and the
included OptiQuant Software (Perkin Elmer).
Statistics
Statistics were performed using GraphPad Prism. One-
way ANOVA followed by Bonferroni’s multiple
comparison was used to compare measures among
three groups. Unpaired t-test analysis was used to
compare measures between two groups. Long rank test
was performed to compare survival distribution between
genotypes. The signiﬁcance between the variables was
shown based on the p-value obtained (ns indicates
p> 0.05,* indicates p< 0.05, ** indicates p< 0.01,
*** indicates p< 0.001 and **** indicates p< 0.0001).
Values are presented as a mean and error bars indicate
standard error means (SEM), unless otherwise stated.
RESULTS AND DISCUSSION
The expression of the TBPH aggregate inducer in
Drosophila CNS does not hamper normal
development
In this study we have exploited our previous work on
Drosophila models for TDP-ALS (Feiguin et al., 2009;
Romano et al., 2014; Cragnaz et al., 2014), and created
a ﬂy TDP-43/TBPH aggregation model centered on the
cellular inclusions of EGFP-12xQ/N. This aggregation
model was previously shown (Budini et al., 2012; Budini
et al., 2014) to be capable of sequestering TDP-43 in cell
lines. To construct the transgenic ﬂy expressing EGFP-
12xQ/N, the construct coding for the protein was placed
under the control of the upstream activating sequence
(UAS). After crossing the transgenic line EGFP-12xQ/N
with the pan-neuronal ELAV-Gal4 (Brand and Perrimon,
1993), brain neurons showed co-localization of Droso-phila TDP-43 (TBPH) with EGFP-12xQ/N aggregates,
as previously reported in the eye tissue (Cragnaz et al.,
2014). The ﬂies developed normally, and no early neuro-
logical toxicity caused by these aggregates was
observed. This is shown by the identical larval peristaltic
waves count both at 25 C and 29 C (the higher temper-
ature accelerates aging in the ﬂies), in larvae expressing
EGFP-12xQ/N or EGFP alone (Fig. 1).EGFP-12xQ/N expression triggers an age-related
locomotion defect in Drosophila
After the pupae stage, the adult ﬂies were kept either at
25 C or 29 C. Also in the adult ﬂy brain, TBPH
co-localized with EGFP-12xQ/N aggregates (data not
shown). The locomotion phenotype was measured by
climbing assay at regular intervals. As shown in Fig. 2,
the climbing ability at 25 C of the transgenic ﬂies
constitutively producing aggregates starts to be
signiﬁcantly lower than the control at 14 days. The ﬂies
kept at 29 C display a climbing deﬁcit already at day 3.
The survival curves follow a similar tendency, with the
25 C and 29 C ﬂies having, respectively, a half-life
20% and 40% shorter than the EGFP control.The locomotion defect follows an age-related
decrease in TBPH levels
A peculiarity of the ﬂies was that notwithstanding the
constitutive production of EGFP-12xQ/N, the resulting
aggregates do not result in a phenotypic consequence
until adulthood. Previous reports have shown that TDP-
43 levels decrease with age in diﬀerent regions of the
mouse brain such as cerebellum, forebrain and
brainstem (Huang et al., 2010; Liu et al., 2015). It was
then decided to investigate whether this programed
reduction of TDP-43 levels arose early in evolution and
can be observed also in non-mammalian species, specif-
ically in Drosophila TBPH expression levels. As it can be
seen in Fig. 3a, the relative TBPH levels decrease during
aging in wild-type ﬂy heads at 25 C and 29 C. It should
Fig. 2. The climbing ability and percentage of survival of EGFP-12xQ/N ﬂies are compromised during aging. (a) Climbing assay and life span
analyses at 25 C (b) and 29 C. Unpaired t-test analysis was used to compare measures between two groups. Long rank test was performed to
compare survival distribution between genotypes. ns indicates p> 0.05 (not signiﬁcant), * indicates p< 0.05, **** indicates p< 0.0001. Error bars
indicate SEM.
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of accelerated aging (29 C). Interestingly, the ﬁnal drop
(4-fold lower than in the immediate after pupa stage) coin-
cides with the time point where the locomotive defect
starts to be visible in the transgenic EGFP-12xQ/N ﬂy
(indicated by an arrow). Furthermore, the same trend in
the levels of endogenous TBPH during aging was also
conﬁrmed in EGFP-12xQ/N- and EGFP-expressing ﬂies
(Fig. 3b). Fig. 3c conﬁrms previous reports of an age-
related decrease of TDP-43 protein levels in mouse brain
samples following a pattern similar to the ﬂy.
To discard an age-related neuronal loss we compared
in ﬂy and mouse the variations of TBPH/TDP-43 levels
during aging with the ﬂuctuation in levels of synapsin, a
strictly neuronal protein (Figs. 3a, c). Data clearly
indicate that the reduction of brain TBPH/TDP-43 levels
is not due to signiﬁcant neuronal loss as in that case a
similar decrease in synapsin would have been
observed. Furthermore, synapsin levels were previously
shown to increase during mouse development between
days 5 and 20 (Bogen et al., 2009). In addition, we are
analyzing relatively young age groups not expected tohave any signiﬁcant neuronal loss. This observation is
also consistent with what has been reported to occur in
humans (Wickelgren 1996).
The lower protein levels correspond to lower mRNA
levels measured by real-time PCR both in ﬂies (Fig. 3d)
and mouse (Fig. 3e, left panel), indicating that there is a
pre-translational mechanism for age-programed
reduction of TDP-43/TBPH levels. The drop in TDP-43
levels in mouse brain was further conﬁrmed by Northern
Blot analyses (Fig. 3e, right panel).
Our data strengthen the hypothesis that the decrease
of TBPH/TDP-43 levels represents an evolutionary
conserved feature characteristic of aging of the
organisms.Constitutive reduction of TBPH levels from birth
anticipates the locomotive defect in EGFP-12xQ/N
expressing ﬂies
If low TBPH levels seen with aging predispose to the
locomotion defects observed upon expression of EGFP-
12xQ/N, it follows that the sensitivity to the presence of
Fig. 3. Drosophila and mouse TDP-43 levels drop during normal aging. (a) Western blot analyses showing endogenous TBPH and synapsin levels
from adult wild-type ﬂy heads aged at 25 C (left panel) and 29 C (right panel). The histograms show the TBPH expression levels normalized with
tubulin. D stands for day. The arrow indicates the point where the climbing ability of the ﬂies is signiﬁcantly reduced (see Fig. 2). Error bars indicate
SD. (b) Western blot analyses showing endogenous TBPH levels from adult (1) ELAV-Gal4/+; UAS-EGFP-12xQ/N/+ and (2) ELAV-Gal4/+;
UAS-EGFP/+ ﬂy heads aged at 25 C. Tubulin was used as loading control. (c) Western blot analyses showing endogenous TDP-43 and synapsin
levels from wild-type mice during aging. The corresponding histogram shows the relative expression levels of TDP-43 normalized with GADPH.
Error bars indicate SD. (d) Real-time PCR quantiﬁcation of ﬂy TBPH at diﬀerent time points. The RNA levels were normalized with Rpl-11. ns
indicates p> 0.05 (not signiﬁcant) and * indicates p< 0.05. Error bars indicate SD. (e) Real-time PCR quantiﬁcation of mouse TDP-43 at diﬀerent
time points (left panel). RNA levels were normalized with GADPH. ns indicates p> 0.05 (not signiﬁcant) and * indicates p< 0.05. Error bars
indicate SD. Northern Blot of mouse TDP-43 at diﬀerent time points (right panel). GADPH was used as loading control.
L. Cragnaz et al. / Neuroscience 311 (2015) 415–421 419
Fig. 4. EGFP-12xQ/N expression induces a defect in larval motility when TBPH levels are down regulated by silencing. (a) Quantiﬁcation of TBPH
level in wild-type (W1118) larval brains and larvae expressing TBPH siRNA. The diﬀerent genotypes are indicated and deﬁned by the color and
number code at the bottom of the ﬁgure. The histogram shows the TBPH expression levels normalized with tubulin. One-way ANOVA followed by
Bonferroni’s multiple comparison was used to compare measures among three groups. ** indicates p< 0.01. Error bars indicate SD. (b)
Quantiﬁcation of peristaltic waves of third instar larvae. A one-way ANOVA followed by Bonferroni’s multiple comparison was used to compare
measures among three groups. ns indicates p> 0.05 (not signiﬁcant) and **** indicates p< 0.0001. Error bars indicate SEM.
420 L. Cragnaz et al. / Neuroscience 311 (2015) 415–421aggregates will be higher in a ﬂy with low TBPH levels
from birth and hence the phenotype should arise earlier
than day 14 of the adult life. To test this hypothesis we
created a ﬂy expressing constitutively a siRNA against
TBPH in neurons. Fig. 4a shows that this ﬂy has from
birth reduced TBPH levels, comparable to 14 day-old
ﬂies, but that this level is suﬃcient for their
development. However, when EGFP-12xQ/N
aggregates are present, the locomotion phenotype can
be already observed at the third instar larval stage at
25 C (Fig. 4b), indicating that the phenotypic
consequence of the EGFP-12xQ/N aggregates is also
dependent on endogenous TDP-43 levels.
Our data demonstrate the existence of a physiological
decrease of TDP-43/TBPH levels with aging in brain
tissue both in wild-type mice and ﬂies, showing that it is
an evolutionary conserved phenomenon. The
maintenance of most functions sustained by TBPH/TDP-
43 depends on the cell capacity of producing this
protein and its availability in a functional form and in the
proper cellular location. Available TDP-43 levels lower
than a certain threshold would lead to abnormal function
of TDP-43 on targets critical for neuronal structure and
function, which might be responsible for the ALS
pathologies.
CONCLUSIONS
Our observations suggest that sequestering of TBPH by
the aggregates in young animals can be overcome by
the higher production of this protein. However, duringaging the lower cellular capacity for TDP-43 production
becomes critical, and the continuous capture of
endogenous TDP-43 by the aggregates will likely
produce a loss of its nuclear function, impossible to be
compensated. Furthermore, the proﬁle of the decline
suggests an evolutionary conserved, programed
reduction during the life span of the organism.
Based on this evidence, we suggest that a critical
event for the onset of the human disease could be an
age-related, physiological drop in TDP-43 expression. At
this point, the continuous capture of endogenous TBPH/
TDP-43 by the aggregates will likely produce a loss of
its nuclear function. We are currently following up these
observations to deﬁnitively prove this point. It should be
noted that, according to this model, aggregates could
exist from a very early stage without causing symptoms.
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